Harrow, Inc. (NASDAQ: HROW), a prominent player in the healthcare sector, has caught the attention of investors with its significant potential upside of 77.74%. Specializing in ophthalmic pharmaceutical products, Harrow..

Harrow, Inc. (NASDAQ: HROW) is drawing significant attention from investors with its promising growth prospects in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. Headquartered in..

Harrow, Inc. (NASDAQ: HROW) stands out in the healthcare sector as a dynamic player specializing in ophthalmic pharmaceutical products. With a market capitalization of $1.36 billion, the Nashville-based company is..

Harrow, Inc. (NASDAQ: HROW) stands out in the healthcare sector, particularly among drug manufacturers specializing in specialty and generic pharmaceuticals. With a market capitalization of $1.31 billion, this Nashville-based company..

Harrow, Inc. (NASDAQ: HROW) stands out as a compelling opportunity within the healthcare sector, specifically in the niche of ophthalmic pharmaceuticals. With its roots dating back to 1998 and a..

Harrow, Inc. (NASDAQ: HROW), a specialized player in the healthcare sector focusing on the development and commercialization of ophthalmic pharmaceutical products, presents an intriguing proposition for investors. With a market..

For investors eyeing opportunities in the healthcare sector, Harrow, Inc. (NASDAQ: HROW) offers an intriguing proposition. Specializing in ophthalmic pharmaceutical products, Harrow has captured the attention of analysts with a..

Harrow, Inc. (NASDAQ: HROW), a key player in the ophthalmic pharmaceutical sector, has been gaining traction among investors due to its robust growth potential and promising analyst ratings. Headquartered in..

Harrow, Inc. (NASDAQ: HROW), a key player in the healthcare sector specializing in ophthalmic pharmaceuticals, is capturing investor attention with significant potential gains on the horizon. With an impressive market..

For investors eyeing opportunities in the healthcare sector, Harrow, Inc. (NASDAQ: HROW) presents a compelling case for consideration. With a market capitalization of $1.1 billion, this Nashville-based eyecare pharmaceutical company..

Harrow, Inc. (NASDAQ: HROW), a prominent player in the eyecare pharmaceutical industry, has recently caught the attention of investors with its promising growth prospects. The company, headquartered in Nashville, Tennessee,..